Cupid Promoter Aditya Kumar Halwasiya Acquires 4.8 Lakh Shares in Open Market Transaction

1 min read     Updated on 31 Mar 2026, 05:10 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Cupid Limited received regulatory disclosure from promoter Aditya Kumar Halwasiya regarding acquisition of 4.8 lakh equity shares through open market purchase. The transaction increased his shareholding from 32.90% to 32.94%, while total promoter group holding rose to 45.89%. The acquisition demonstrates management confidence and was conducted in full compliance with SEBI takeover regulations.

powered bylight_fuzz_icon
36427289

*this image is generated using AI for illustrative purposes only.

Cupid experienced notable promoter activity with Aditya Kumar Halwasiya acquiring a substantial stake through open market purchases. The transaction demonstrates active participation by the company's leadership in the equity markets and was conducted in compliance with SEBI regulations.

Regulatory Disclosure Details

The company received formal disclosure from Mr. Aditya Kumar Halwasiya under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was submitted to both BSE Limited and National Stock Exchange of India Limited.

Parameter: Details
Promoter Name: Aditya Kumar Halwasiya
Shares Acquired: 4.8 lakh
Transaction Date: March 30
Transaction Type: Open Market Purchase
Face Value: Re. 1/- each

Shareholding Pattern Changes

The acquisition resulted in changes to the promoter's shareholding in the company. The detailed shareholding information shows the impact on overall promoter group holdings.

Shareholding Details: Before Acquisition After Acquisition
Aditya Kumar Halwasiya Shares: 44,24,45,475 44,29,25,475
Percentage Holding: 32.90% 32.94%
Total Promoter Group: 61,66,44,725 61,71,24,725
Combined Percentage: 45.85% 45.89%

Market Implications

Promoter purchases in the open market are typically interpreted as positive signals by market participants. Such transactions often indicate management confidence in company fundamentals and belief in future growth prospects. The acquisition represents a strategic positioning by the promoter, reflecting active engagement with the company's equity structure.

Company Structure

Cupid Limited operates as a manufacturer and exporter of male condoms, female condoms, water-based lubricants, and In Vitro Diagnostics (IVD) kits. The company is listed on both BSE Limited (Scrip Code: 530843) and National Stock Exchange of India Limited (Scrip Code: CUPID), with its registered office located in Nashik, Maharashtra.

Regulatory Compliance

The transaction was conducted through open market mechanisms, ensuring transparency and regulatory compliance. Company Secretary and Compliance Officer Saurabh V. Karmase facilitated the disclosure process, ensuring all stakeholders were informed of the ownership changes in accordance with regulatory requirements.

Historical Stock Returns for Cupid

1 Day5 Days1 Month6 Months1 Year5 Years
-1.83%+4.40%+2.19%+92.81%+553.82%+689.92%

Will Aditya Kumar Halwasiya continue increasing his stake to reach the 35% threshold that would trigger a mandatory open offer?

How might this promoter confidence signal impact Cupid's upcoming product launches or expansion plans in the contraceptive and IVD markets?

Could this stake increase indicate potential strategic partnerships or acquisitions in Cupid's healthcare portfolio?

Cupid Limited Reconstitutes Audit Committee with Three Independent Directors

1 min read     Updated on 31 Mar 2026, 12:02 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Cupid Limited reconstituted its Audit Committee on March 30, 2026, appointing Mrs. Rajni Mishra as Chairperson along with two other independent directors as members. The Board resolution was passed by circulation and communicated to stock exchanges under SEBI regulations. This governance update ensures continued compliance with listing requirements for the healthcare products manufacturer.

powered bylight_fuzz_icon
36441147

*this image is generated using AI for illustrative purposes only.

Cupid Limited has announced the reconstitution of its Audit Committee through a Board resolution passed by circulation on March 30, 2026. The healthcare products manufacturer communicated this corporate governance update to both BSE and NSE under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Committee Composition

The reconstituted Audit Committee comprises three members, all holding Non-Executive & Independent Director positions. The new structure ensures compliance with corporate governance norms for listed companies.

Position Name Category
Chairperson Mrs. Rajni Mishra Non-Executive & Independent Director
Member Mr. Thallapaka Venkateswara Rao Non-Executive & Independent Director
Member Mr. Bontha Prasada Rao Non-Executive & Independent Director

Regulatory Compliance

The company filed the mandatory disclosure with stock exchanges to inform stakeholders about the committee changes. Company Secretary and Compliance Officer Saurabh V. Karmase digitally signed the regulatory filing on March 30, 2026.

Company Background

Cupid Limited operates as a manufacturer and exporter of male condoms, female condoms, water-based lubricants, and In Vitro Diagnostics (IVD) kits. The company is headquartered at A-68, M.I.D.C. (Malegaon), Sinnar, Nashik, Maharashtra, and trades on BSE under scrip code 530843 and NSE under scrip code CUPID.

The reconstitution reflects the company's commitment to maintaining robust corporate governance practices through independent oversight of its audit functions.

Historical Stock Returns for Cupid

1 Day5 Days1 Month6 Months1 Year5 Years
-1.83%+4.40%+2.19%+92.81%+553.82%+689.92%

What strategic initiatives or financial challenges might have prompted Cupid Limited to reconstitute its entire Audit Committee with new independent directors?

How could this governance restructuring impact Cupid's upcoming financial audits and potential regulatory scrutiny in the healthcare products sector?

Will the new Audit Committee composition influence Cupid's expansion plans in the IVD kits segment, given the increased regulatory oversight in diagnostics post-pandemic?

More News on Cupid

1 Year Returns:+553.82%